严重创伤患者接受氨甲环酸与纤溶关闭风险增加相关
该研究回顾了2011年8月至2015年1月城市一级创伤中心ICU收治的218例危重创伤成人患者,入ICU时行血栓弹力图检查,按LY30≤0.8%定义纤溶关闭。64%发生纤溶关闭,16%接受氨甲环酸。纤溶关闭组初始收缩压更低(114±38 vs 129±43 mm Hg,p=0.006)、碱缺失更重(-5±6 vs -3±5 mEq/L,p=0.013),输血更多,接受氨甲环酸比例更高(23% vs 4%,p<0.0001)。控制混杂后氨甲环酸(RR 1.35,95%CI 1.10-1.64,p=0.004)与冷沉淀输注(RR 1.29,95%CI 1.07-1.56,p=0.007)与纤溶关闭独立相关。作者建议氨甲环酸仅限用于有纤溶亢进证据的严重创伤患者,对有纤溶关闭证据者慎用。
要点
- 严重创伤入ICU患者中64%发生纤溶关闭(LY30≤0.8%),接受氨甲环酸者纤溶关闭比例更高(23% vs 4%,p<0.0001)。
- 控制混杂后氨甲环酸与纤溶关闭独立相关(RR 1.35,95%CI 1.10-1.64,p=0.004)。
- 冷沉淀输注亦与纤溶关闭独立相关(RR 1.29,95%CI 1.07-1.56,p=0.007)。
- 纤溶关闭组初始收缩压更低(114±38 vs 129±43 mm Hg,p=0.006)、碱缺失更重(-5±6 vs -3±5 mEq/L,p=0.013)。
- 作者建议氨甲环酸仅限用于有纤溶亢进证据的严重创伤患者,对有纤溶关闭证据者慎用。
适用人群与场景
- 2011年8月至2015年1月城市一级创伤中心ICU收治的218例危重创伤成人患者,入ICU时行血栓弹力图检查。
- 患者年龄46±18岁,81%男性,75%钝性创伤,损伤严重度评分28±13。
诊断标准与关键阈值
- 纤溶关闭定义为LY30≤0.8%。
研究设计与关键结果
- 回顾性研究,218例危重创伤成人,64%发生纤溶关闭,16%接受氨甲环酸,死亡率15%。
- 纤溶关闭组初始收缩压114±38 mm Hg vs 非关闭组129±43 mm Hg(p=0.006),碱缺失-5±6 mEq/L vs -3±5 mEq/L(p=0.013)。
- 纤溶关闭组24小时内输注浓缩红细胞6(2-11)U vs 2(1-5)U(p<0.0001),新鲜冰冻血浆3(0-8)U vs 0(0-4)U(p<0.0001)。
- 纤溶关闭组接受氨甲环酸比例23% vs 4%(p<0.0001)。
- 控制混杂后氨甲环酸与纤溶关闭独立相关(RR 1.35,95%CI 1.10-1.64,p=0.004),冷沉淀输注亦独立相关(RR 1.29,95%CI 1.07-1.56,p=0.007)。
证据类型、等级与局限
- 证据类型:回顾性研究;证据等级:治疗性,III级。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者建议氨甲环酸仅限用于有纤溶亢进证据的严重创伤患者,对有纤溶关闭证据者慎用。
- 接受氨甲环酸者纤溶关闭风险升高(RR 1.35,95%CI 1.10-1.64),床旁决策需结合血栓弹力图LY30评估纤溶状态。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The association between tranexamic acid (TXA) and fibrinolysis shutdown is unknown. We hypothesize that TXA is associated with fibrinolysis shutdown in critically injured trauma patients.
METHODS: Two hundred eighteen critically injured adults admitted to the intensive care unit at an urban Level I trauma center from August 2011 to January 2015 who had thromboelastography performed upon intensive care unit admission were reviewed. Groups were stratified based on fibrinolysis shutdown, which was defined as LY30 of 0.8% or less. Continuous variables were expressed as mean ± standard deviation or median (interquartile range). Poisson regression analysis was used to determine predictors of shutdown.
RESULTS: Patients were age 46 ± 18 years, 81% male, 75% blunt trauma, Injury Severity Score of 28 ± 13, 16% received TXA, 64% developed fibrinolysis shutdown, and mortality was 15%. In the first 24 hours, 4 (2-9) units packed red blood cells and 2 (0-6) units fresh frozen plasma were administered. Those with shutdown had worse initial systolic blood pressure (114 ± 38 mm Hg vs. 129 ± 43 mm Hg, p = 0.006) and base deficit (-5 ± 6 mEq/L vs -3 ± 5 mEq/L, p = 0.013); received more packed red blood cells [6 (2-11) vs. 2 (1-5) units, p < 0.0001], and fresh frozen plasma [3 (0-8) vs. 0 (0-4) units, p < 0.0001]; and more often received TXA (23% vs. 4%, p <0.0001). After controlling for confounders, TXA (relative risk, 1.35; 95% confidence interval, 1.10-1.64; p = 0.004) and cryoprecipitate transfusion (relative risk, 1.29; 95% confidence interval, 1.07-1.56; p = 0.007) were independently associated with fibrinolysis shutdown.
CONCLUSION: Patients who received TXA were at increased risk of fibrinolysis shutdown compared with patients who did not receive TXA. We recommend that administration of TXA be limited to severely injured patients with evidence of hyperfibrinolysis and recommend caution in those with evidence of fibrinolysis shutdown.
LEVEL OF EVIDENCE: Therapeutic, level III.
参考来源
- Meizoso JP, Dudaryk R, Mulder MB, et al. Increased risk of fibrinolysis shutdown among severely injured trauma patients receiving tranexamic acid. J Trauma Acute Care Surg. 2018. PMID: 29298240. doi:10.1097/TA.0000000000001792
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。